Request Deal Involvement

SR One led a $200m Series C round in Zenas BioPharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Ropes & Gray

legal advisors

Ropes & Gray

Argot Partners

pr advisors

Argot Partners

or

Principals

ZENAS BIOPHARMA

target

ZENAS BIOPHARMA

FEDERATED HERMES

bidder

FEDERATED HERMES

SR ONE LTD

bidder

SR ONE LTD

NORWEST VENTURE PARTNERS

bidder

NORWEST VENTURE PARTNERS

NEW ENTERPRISE ASSOCIATES (NEA)

bidder

NEW ENTERPRISE ASSOCIATES (NEA)

DELOS CAPITAL

bidder

DELOS CAPITAL

ENAVATE SCIENCES

bidder

ENAVATE SCIENCES

FAIRMOUNT FUNDS MANAGEMENT

bidder

FAIRMOUNT FUNDS MANAGEMENT

ROCK SPRINGS CAPITAL

bidder

ROCK SPRINGS CAPITAL

LONGITUDE CAPITAL MANAGEMENT CO LLC

bidder

LONGITUDE CAPITAL MANAGEMENT CO LLC

ARROWMARK PARTNERS

bidder

ARROWMARK PARTNERS

WELLINGTON MANAGEMENT

bidder

WELLINGTON MANAGEMENT

PIVOTAL BIOVENTURE PARTNERS LLC

bidder

PIVOTAL BIOVENTURE PARTNERS LLC

VIVO CAPITAL LLC

bidder

VIVO CAPITAL LLC

SUPERSTRING CAPITAL

bidder

SUPERSTRING CAPITAL

QUAN VENTURE FUND

bidder

QUAN VENTURE FUND

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - SR One led a $200m Series C round in Zenas BioPharma.